Kirsten LundJurgensen - UCB SA Ex Solutions

UCB Stock

EUR 182.45 2.40 1.30%

Insider

Kirsten LundJurgensen is Ex Solutions of UCB SA

Age	64
Phone	32 2 559 99 99
Web	https://www.ucb.com

UCB SA Management Efficiency

The company has return on total asset (ROA) of 0.0468 % which means that it generated a profit of $0.0468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1069 %, meaning that it generated $0.1069 on every $100 dollars invested by stockholders. UCB SA's management efficiency ratios could be used to measure how well UCB SA manages its routine affairs as well as how well it operates its assets and liabilities.

Compare UCB SA to Peers

Predict price of UCB SA

UCB SA has accumulated 1.97 B in total debt with debt to equity ratio (D/E) of 23.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. UCB SA has a current ratio of 1.29, suggesting that it may not have the ability to pay its financial obligations in time and when they become due. Debt can assist UCB SA until it has trouble settling it off, either with new capital or with free cash flow. So, UCB SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UCB SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UCB to invest in growth at high rates of return. When we think about UCB SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Philippe Debelle	Groep Brussel Lambert	N/A
	Gary Crist	ageas SANV	66
	Marc Chollet	Solvay SA	59
	Pascal Reynaerts	Groep Brussel Lambert	N/A
	Filip Coremans	ageas SANV	59
	Augusto Donfrancesco	Solvay SA	64
	Viviane Huybrecht	KBC Groep NV	N/A
	Geoffroy Raskin	Solvay SA	N/A
	Christophe Boizard	ageas SANV	64
	Peter Andronov	KBC Groep NV	54
	Bart Smet	ageas SANV	66
	Sophia Harms	Groep Brussel Lambert	N/A
	Nathalie Ypersele	Solvay SA	N/A
	Roger Popelier	KBC Groep NV	59
	Steven Braekeveldt	ageas SANV	63
	Jerry Bata	ageas SANV	N/A
	An Herremans	Ackermans Van Haaren	41
	Antonio Bosque	ageas SANV	60
	Jodi Allen	Solvay SA	N/A
	Katia Waegemans	Ackermans Van Haaren	N/A
	Hari Rajmohan	Ackermans Van Haaren	N/A

UCB SA, a biopharmaceutical company, researches, develops, manufactures, sells, and distributes biopharmaceutical solutions for people living with neurology and immunology conditions. The company was founded in 1928 and is headquartered in Brussels, Belgium. UCB SA operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 6828 people. UCB SA (UCB) is traded on Euronext Brussels in Belgium and employs 8,600 people.

Management Performance

	Return On Equity	0.11
	Return On Asset	0.0468

UCB SA Leadership Team

Elected by the shareholders, the UCB SA's board of directors comprises two types of representatives: UCB SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UCB. The board's role is to monitor UCB SA's management team and ensure that shareholders' interests are well served. UCB SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UCB SA's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Sandrine CFA, Ex CFO
	Emmanuel Caeymaex, Executive Vice President Immunology - Patient Value Unit Head
	William Silbey, Exec Counsel
	Pr LowFriedrich, Chief VP
	Charl Zyl, Executive Vice President Head of Patient Value Operations, Member of the Executive Committee
	Kirsten LundJurgensen, Ex Solutions
	Caroline Vancoillie, Chief Functions
	JeanLuc Fleurial, Executive Vice President Chief Talent Officer, Member of the Executive Committee
	JeanChristophe Tellier, Chairman of the Executive Committee, CEO

UCB Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UCB SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	0.11
	Return On Asset	0.0468
	Profit Margin	0.15 %
	Operating Margin	0.19 %
	Current Valuation	15.81 B
	Shares Outstanding	189.96 M
	Shares Owned By Insiders	38.03 %
	Shares Owned By Institutions	40.78 %
	Price To Earning	17.19 X
	Price To Book	1.55 X

Pair Trading with UCB SA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if UCB SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UCB SA will appreciate offsetting losses from the drop in the long position's value.

Moving together with UCB Stock

0.83	TUB	Tubize Fin	Pair Corr
0.65	NYR	Nyrstar NV	Pair Corr

Moving against UCB Stock

0.82

VGP

VGP NV

Pair Corr

The ability to find closely correlated positions to UCB SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace UCB SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back UCB SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling UCB SA to buy it.

The correlation of UCB SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UCB SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UCB SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for UCB SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for UCB Stock Analysis

When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC